603309 Stock Overview
Engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Well Lead Medical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.45 |
| 52 Week High | CN¥14.67 |
| 52 Week Low | CN¥8.52 |
| Beta | -0.26 |
| 1 Month Change | -4.45% |
| 3 Month Change | 20.52% |
| 1 Year Change | -7.57% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603309 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 0.6% | 0.1% | 0.4% |
| 1Y | -7.6% | -8.5% | 12.3% |
Return vs Industry: 603309 exceeded the CN Medical Equipment industry which returned -10.4% over the past year.
Return vs Market: 603309 underperformed the CN Market which returned 9.8% over the past year.
Price Volatility
| 603309 volatility | |
|---|---|
| 603309 Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 603309 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603309's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 2,622 | Guangyuan Han | www.wellead.com |
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide. It manufactures and sells urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial tubes, tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products; respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and Convicath intermittent catheter; and ambulatory infusion pump for pain management. The company was founded in 1998 and is headquartered in Guangzhou, China.
Well Lead Medical Co., Ltd. Fundamentals Summary
| 603309 fundamental statistics | |
|---|---|
| Market cap | CN¥3.65b |
| Earnings (TTM) | CN¥215.29m |
| Revenue (TTM) | CN¥1.47b |
16.9x
P/E Ratio2.5x
P/S RatioIs 603309 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603309 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.47b |
| Cost of Revenue | CN¥814.44m |
| Gross Profit | CN¥656.61m |
| Other Expenses | CN¥441.31m |
| Earnings | CN¥215.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.74 |
| Gross Margin | 44.64% |
| Net Profit Margin | 14.64% |
| Debt/Equity Ratio | 29.6% |
How did 603309 perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield68%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 15:41 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Well Lead Medical Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jingning Long | Chasing Securities |